ONCY
Oncolytics Biotech Inc
0.5969$
-5.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.4% | 98.3% | 96.1% | 95.5% | 94.4% | 93.5% | 93.8% | 94.6% | 93.3% | 90.3% | 91.7% | 92.2% | |
| 86.7% | 89.9% | 85.2% | 77.5% | 80.8% | 79.0% | 77.7% | 73.2% | 82.0% | 68.6% | 67.3% | 53.6% | |
| 86.7% | 89.9% | 85.2% | 77.5% | 80.8% | 79.0% | 77.7% | 73.2% | 82.0% | 68.6% | 67.3% | 53.6% | |
| 1.4% | 0.0% | 0.3% | 4.9% | 0.4% | 0.3% | 0.5% | 0.4% | 0.4% | 7.6% | 11.8% | 15.8% | |
| 37.0% | 29.0% | 33.9% | 42.9% | 62.7% | 70.4% | 67.0% | 69.5% | 99.2% | 150.1% | 162.9% | 180.4% | |
| 21.7% | 10.9% | 11.8% | 19.1% | 31.6% | 33.1% | 29.3% | 32.8% | 50.8% | 80.5% | 66.5% | 68.1% | |
| 0.4% | 0.3% | 0.5% | 0.7% | 1.0% | 1.4% | 1.5% | 1.5% | 1.8% | 2.5% | 2.0% | 1.8% | |
| 4.7% | 2.8% | 2.1% | 2.8% | 14.1% | 5.4% | 4.0% | 6.7% | 27.9% | 46.2% | 32.9% | 44.4% | |
| 63.0% | 71.0% | 66.1% | 57.1% | 37.3% | 29.6% | 33.0% | 30.5% | 0.8% | -50.1% | -62.9% | -80.4% | |
| -959.1% | -1,148.9% | -1,303.3% | -1,434.9% | -1,935.9% | -2,366.4% | -2,458.6% | -2,456.0% | -3,353.7% | -5,664.7% | -5,376.0% | -5,842.5% | |
| 151.5% | 189.9% | 216.5% | 237.3% | 317.4% | 396.4% | 429.6% | 455.6% | 672.9% | 1,424.7% | 1,376.0% | 1,560.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.